#VCNX
LightNews LightNews
www.keroncho.org
スカ・ジャズ・メッセンジャーズ + エマーソン北村 『どこゆくの』(walkin' in the clouds version) 🌇
www.youtube.com/watch?v=VcNx...
スカ・ジャズ・メッセンジャーズ + エマーソン北村 『どこゆくの』(walkin' in the clouds version) 🌇
YouTube video by Ska Jazz Messengers SJM
www.youtube.com
October 7, 2025 at 11:30 AM
cycling74.bsky.social
⚡️ Our live patching session with Ned Rush is starting soon! You won't want to miss it! 🎛️

Join us here!👇
🔗 www.youtube.com/watch?v=vCnx...
January 21, 2026 at 5:59 PM
marketwirenews.com
News; ( NASDAQ: #VCNX ) Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer's Disease and Plans to Pursue a Development Partnership

#StockMarket #News
August 14, 2024 at 5:40 PM
marketwirenews.com
BREAKING NEWS: ( NASDAQ: #VCNX ) Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer's Disease (CTAD) Conference on October 31, 2024

#StockMarket #News
October 24, 2024 at 3:15 PM
www.keroncho.org
スカ・ジャズ・メッセンジャーズ + エマーソン北村 『どこゆくの』(walkin' in the clouds version) 🌇
www.youtube.com/watch?v=VcNx...
スカ・ジャズ・メッセンジャーズ + エマーソン北村 『どこゆくの』(walkin' in the clouds version) 🌇
YouTube video by Ska Jazz Messengers SJM
www.youtube.com
December 28, 2024 at 8:14 PM
thekenyatimes.com
Read more on this story: thekenyatimes.com/vcnx
CS Joho To Hand Another Tract Of Narok Land To Private Investor
Cabinet Secretary for Mining, Blue Economy and Maritime Affairs Hassan Ali Joho is set to hand another tract of Narok Land to private investor.
thekenyatimes.com
September 20, 2026 at 7:17 AM
newsarea.bsky.social
Vaccinex (VCNX) Projected to Post Earnings on Monday

Vaccinex (NASDAQ:VCNX – Get Free Report) is projected to announce its resultson Monday, August 10th. Analysts expect Vaccinex to post earnings of ($73.0380) per share and revenue of $0.63 million for the quarter. Vaccinex Price Performance…
Vaccinex (VCNX) Projected to Post Earnings on Monday
Vaccinex (NASDAQ:VCNX – Get Free Report) is projected to announce its resultson Monday, August 10th. Analysts expect Vaccinex to post earnings of ($73.0380) per share and revenue of $0.63 million for the quarter. Vaccinex Price Performance Shares of NASDAQ VCNX opened at $0.99 on Friday. The company has a market cap of $2.57 million, a [...]
news-area.com
August 9, 2026 at 5:58 PM
m0n5t3r.bsky.social
youtube.com/watch?v=vCnx...
White Americans are angry that they were raised in hate.
YouTube video by World Moving Trends
youtube.com
July 11, 2026 at 12:48 PM
adrianodecordoba.bsky.social
🔴💥🇪 🇸 🇹 🇷 🇪 🇳 🇴💥🔴
✳️🇦🇷😍🇨 🇧 🇦✳️
✨🕊️❤️1️⃣3️⃣🎄1️⃣2️⃣🎄‍2️⃣4️⃣❤️🕊️✨🕰️23:30 ▪️✌️🇲🇽✌️▪️
🔥💥🌎DETRÁS DE LA RAZÓN🌍💥🔥
✔️Roberto de la Madrid
✔️JAVIER MARTÍNEZ
💢DESAPARICIÓN DE SIRIA ... SIGUE IRÁN?
🔴Exclusiva: Declaraciones de Netanyahu • Planes ocultos desde 1999.
www.youtube.com/watch?v=vCnx...
DESAPARICIÓN DE SIRIA 💥 Exclusiva: planes ocultos desde 1999 ¿QUÉ SIGUE DISPUTA #EEUU #RUSIA #ISRAEL
YouTube video by Detrás de la Razón
www.youtube.com
December 14, 2024 at 2:31 AM
butterlfy.bsky.social
www.youtube.com/watch?v=vcNx...
우리 군 정찰위성 3호기 발사 성공의 역사적 순간!!
YouTube video by 방위사업청
www.youtube.com
December 23, 2024 at 2:36 AM
dekmartrades.bsky.social
$VCNX Vaccinex to Report Promising New Clinical Data Revealing Pepinemab's Unique Mechanism to Enhance Immunotherapy at Annual Meeting of American Association for Cancer Research (AACR)

foxrunner.com?fpr=newsscan...
April 21, 2025 at 12:55 PM
handle.invalid
Top Gainers & Losers

🟢 $SBET $KTTA $MRIN $AIFU $BLMZ $VCNX $EVGO $SXTC $FARO $PNST

🔴 $NCNA $PKBO $TCBP $MMV $KRBP $BIAF $LKCO $APTO $BHIL $CTHR
May 6, 2025 at 3:52 PM
handle.invalid
Recent Gap Ups
🟢 $SBET $MRIN $BLMZ $AIFU $VCNX $KTTA $SYRA $SXTC $FARO $AREB

Recent Gap Downs
🔴 $CTHR $PKBO $NCNA $APTO $TCMD $SEAT $BIAF $VSME $NITO $YCBD
May 6, 2025 at 2:49 PM
handle.invalid
Top Gainers & Losers

🟢 $AVTE $RGLS $DMN $ALCE $VCNX $RCKY $NVNI $MCOM $JFBR $WW

🔴 $NVOS $PKBO $TCBP $EJH $MMV $KRBP $LKCO $APTO $CTHR $BHIL
April 30, 2025 at 4:26 PM
handle.invalid
Recent Gap UPS
🟢 $TGL $MIRA $ARBB $VCNX $NB $OMEX $HTZ $PNST $WTER $GETR

Recent Gap Downs
🔴 $PKBO $OST $APTO $BLMZ $TRUG $YHC $BMRA $VIRX $RDHL $XIN
April 16, 2025 at 3:01 PM
handle.invalid
Recent Gap Ups
🟢 $XXII $VRPX $RSLS $NVOS $TTOO $LUXH $ELAB $ALCE $VCNX $SGN

Recent Gap Downs
🔴 $PKBO $VERO $MRIN $APTO $WAI $AEHL $VEEE $AGH $NEOG $PGHL

Click here for more:
app.afterpullback.com
April 10, 2025 at 2:16 PM
handle.invalid
Recent Gap Ups
🟢 $XXII $BTOG $GLXG $NXU $VCNX $WORX $ONCO $SXTP $CRKN $GETR

Recent Gap Downs
🔴 $FMTO $PKBO $BJDX $RLYB $APTO $LFLY $CVRX $STTK $RTC $SNAX
April 9, 2025 at 2:24 PM
handle.invalid
Recent Gap Ups
$AEHL $FTFT $SOBR $CISS $IBO

Recent Gap Downs
$PKBO $VCNX $NMTC $APTO $LNZA
April 4, 2025 at 4:16 PM
handle.invalid
Recent Gap Ups
🟢 $WHLR $LYT $GTEC $DRMA

Recent Gap Downs
🔴 $BACK $PKBO $NVOS $VCNX
March 27, 2025 at 2:47 PM
handle.invalid
Recent Gap Ups
🟢 $LGHL $NVOS $OSRH $PTPI $SURG

Recent Gap Downs
🔴 $PKBO $BACK $VCNX $ACON $HUMA
March 26, 2025 at 3:03 PM
stocktitan.net
#VCNX Vaccinex Reports 2025 Annual Financial Results

https://www.stocktitan.net/news/VCNX/vaccinex-reports-2025-annual-financial-ao89p9l9uxsh.html
Vaccinex Reports 2025 Annual Financial Results
Vaccinex (OTCMKTS: VCNX) reported it released its 2025 annual financial results for the year ended December 31, 2025 and posted the financial statements on its website on April 29, 2026. The company is a clinical-stage developer of investigational antibody therapies for Alzheimer’s, Huntington’s, and cancer.
www.stocktitan.net
April 30, 2026 at 12:05 AM
stocktitan.net
#VCNX Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease

https://www.stocktitan.net/news/VCNX/vaccinex-inc-announces-60-million-agreement-to-finance-a-phase-2b-jjqbi6ybk54a.html
Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease
Vaccinex (NASDAQ:VCNX) announced a $60 million revenue‑sharing financing with Pepinemab Development Venture LP to fund an enlarged Phase 2b trial of pepinemab for Alzheimer’s disease on Dec 23, 2025. The deal gives PDV 50% of future economic proceeds from neurological pepinemab licenses and 25% for other indications. Company cites prior SIGNAL‑AD Phase 1/2a and HD Phase 2 data showing tolerability, biomarker effects, reduced Ast10 astrocyte representation, and signals of slowed cognitive decline; results were reported at CTAD on Dec 3, 2025.
www.stocktitan.net
December 23, 2025 at 1:01 PM
stocktitan.net
#VCNX Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market

https://www.stocktitan.net/news/VCNX/vaccinex-plans-to-delist-its-common-stock-from-the-nasdaq-stock-3q5q51pb679p.html
Can Vaccinex Survive After Nasdaq Exit? Key Details on Company's Future Strategy
Biotech firm faces voluntary delisting by March 2025 but maintains focus on Alzheimer's and cancer drug development through alternative funding sources.
www.stocktitan.net
March 7, 2025 at 10:15 PM
stocktitan.net
#VCNX Vaccinex Announces Receipt of Delisting Notification from Nasdaq

https://www.stocktitan.net/news/VCNX/vaccinex-announces-receipt-of-delisting-notification-from-0nunbks82viw.html
Vaccinex Faces Nasdaq Delisting After Failing Minimum Equity Requirements, Moves to OTC Markets
Vaccinex (VCNX) set to be delisted from Nasdaq following failure to maintain $2.5M stockholders' equity requirement. Trading suspension effective Dec 18, moving to OTC Markets.
www.stocktitan.net
December 17, 2024 at 2:00 PM